Pengfei Li

4.6k total citations · 2 hit papers
157 papers, 3.4k citations indexed

About

Pengfei Li is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Pengfei Li has authored 157 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in Molecular Biology, 26 papers in Oncology and 26 papers in Cancer Research. Recurrent topics in Pengfei Li's work include RNA modifications and cancer (15 papers), Glycosylation and Glycoproteins Research (15 papers) and Cancer-related molecular mechanisms research (15 papers). Pengfei Li is often cited by papers focused on RNA modifications and cancer (15 papers), Glycosylation and Glycoproteins Research (15 papers) and Cancer-related molecular mechanisms research (15 papers). Pengfei Li collaborates with scholars based in China, United States and Germany. Pengfei Li's co-authors include Huanjie Shao, Yihong Zhan, Qi Miao, Xiaohui Yan, Ting Wang, Shisheng Sun, Jingkang Wang, Baosheng Zhao, Chunguo Wang and Ziyan Tang and has published in prestigious journals such as Advanced Materials, Angewandte Chemie International Edition and Journal of Clinical Investigation.

In The Last Decade

Pengfei Li

143 papers receiving 3.3k citations

Hit Papers

Apigenin in cancer therap... 2017 2026 2020 2023 2017 2019 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pengfei Li China 31 1.9k 440 380 380 378 157 3.4k
Fahad A. Al‐Abbasi Saudi Arabia 33 1.6k 0.9× 391 0.9× 324 0.9× 314 0.8× 266 0.7× 252 4.3k
Kang Li China 33 2.1k 1.1× 593 1.3× 260 0.7× 560 1.5× 449 1.2× 163 4.1k
Qing Zhang China 35 2.1k 1.1× 467 1.1× 305 0.8× 386 1.0× 486 1.3× 135 4.5k
Xiaoyan Wang China 35 2.0k 1.1× 402 0.9× 199 0.5× 393 1.0× 218 0.6× 135 3.7k
Kai‐Li Liu China 39 1.9k 1.0× 336 0.8× 371 1.0× 533 1.4× 470 1.2× 196 4.6k
Xianli Meng China 37 1.9k 1.0× 347 0.8× 636 1.7× 303 0.8× 342 0.9× 155 4.2k
Chiara Dianzani Italy 42 2.0k 1.1× 344 0.8× 211 0.6× 369 1.0× 694 1.8× 124 4.8k
Sami I. Alzarea Saudi Arabia 35 1.7k 0.9× 993 2.3× 239 0.6× 312 0.8× 222 0.6× 199 4.1k
Liping Chen China 33 2.0k 1.1× 725 1.6× 235 0.6× 395 1.0× 238 0.6× 221 3.8k
Elizandra Braganhol Brazil 36 1.5k 0.8× 422 1.0× 197 0.5× 180 0.5× 510 1.3× 124 3.9k

Countries citing papers authored by Pengfei Li

Since Specialization
Citations

This map shows the geographic impact of Pengfei Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pengfei Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pengfei Li more than expected).

Fields of papers citing papers by Pengfei Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pengfei Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pengfei Li. The network helps show where Pengfei Li may publish in the future.

Co-authorship network of co-authors of Pengfei Li

This figure shows the co-authorship network connecting the top 25 collaborators of Pengfei Li. A scholar is included among the top collaborators of Pengfei Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pengfei Li. Pengfei Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Feng, Tingze, Pengfei Li, Siyi Li, et al.. (2025). Metabolic state uncovers prognosis insights of esophageal squamous cell carcinoma patients. Journal of Translational Medicine. 23(1). 342–342. 2 indexed citations
2.
Li, Pengfei, Zhibin Peng, Yubo Zhang, et al.. (2025). Nasal Delivery of Engineered Exosomes via a Thermo‐Sensitive Hydrogel Depot Reprograms Glial Cells for Spinal Cord Repair. Advanced Science. 12(34). e04486–e04486. 3 indexed citations
5.
Yang, Yi, et al.. (2024). Berberine alleviates diabetic retinopathy by regulating the Th17/Treg ratio. Immunology Letters. 267. 106862–106862. 10 indexed citations
6.
Rozi, Parhat, et al.. (2024). Isolation, structure identification, and antioxidant activity of collagen peptides from horse bone marrow. Journal of Food Measurement & Characterization. 18(6). 4074–4087. 3 indexed citations
7.
Wang, Changyu, Qianwei Zhang, Yang Liu, et al.. (2024). Effects of dual-phase deformation behaviors on simultaneously enhanced tensile properties and stress corrosion resistance of 2Cr13 martensitic stainless steel treated by laser shock peening. Surface and Coatings Technology. 494. 131379–131379. 6 indexed citations
8.
Zhu, Lin, Wanqing Yang, Shengyan Xi, et al.. (2024). Regulatory effect of Yinchenhao decoction on bile acid metabolism to improve the inflammatory microenvironment of hepatocellular carcinoma in mice. Journal of Natural Medicines. 78(3). 633–643. 3 indexed citations
9.
10.
Zhang, Yubo, Zhibin Peng, Yangyang Wang, et al.. (2024). TET3-facilitated differentiation of human umbilical cord mesenchymal stem cells into oligodendrocyte precursor cells for spinal cord injury recovery. Journal of Translational Medicine. 22(1). 1118–1118. 3 indexed citations
11.
Dang, Liuyi, Pengfei Li, Huanhuan Liu, et al.. (2023). Glycoproteomic analysis of regulatory effects of bisecting N-glycans on N-glycan biosynthesis and protein expressions in human HK-2 cells. Carbohydrate Research. 531. 108894–108894. 1 indexed citations
12.
Li, Cheng, Pengfei Li, Miaomiao Xin, et al.. (2023). Site-specific N-glycan changes during semen liquefaction. Analytical Biochemistry. 680. 115318–115318. 2 indexed citations
13.
Li, Pengfei, et al.. (2023). YBX-1 alleviates sepsis-stimulated lung epithelial cell injury. Allergologia et Immunopathologia. 52(2). 60–67.
14.
Lin, Hui, et al.. (2023). Analysis and modification of central carbon metabolism in Hypsizygus marmoreus for improving mycelial growth performance and fruiting body yield. Frontiers in Microbiology. 14. 1233512–1233512. 5 indexed citations
15.
Liu, Qilong, Xiaojing Liu, Rongqing Sun, et al.. (2023). Diagnostic performance and clinical impact of blood metagenomic next-generation sequencing in ICU patients suspected monomicrobial and polymicrobial bloodstream infections. Frontiers in Cellular and Infection Microbiology. 13. 1192931–1192931. 13 indexed citations
18.
Liang, Tongzhou, Taiqiu Chen, Jincheng Qiu, et al.. (2021). Inhibition of nuclear receptor RORα attenuates cartilage damage in osteoarthritis by modulating IL-6/STAT3 pathway. Cell Death and Disease. 12(10). 886–886. 34 indexed citations
19.
Zhong, Yuanyuan, Jiekun Luo, Tao Tang, et al.. (2018). Exploring Pharmacological Mechanisms of Xuefu Zhuyu Decoction in the Treatment of Traumatic Brain Injury via a Network Pharmacology Approach. Evidence-based Complementary and Alternative Medicine. 2018(1). 8916938–8916938. 32 indexed citations
20.
Wang, Zifeng, Jiajun Xie, Min Yan, et al.. (2016). Downregulation of ATOH8 induced by EBV-encoded LMP1 contributes to the malignant phenotype of nasopharyngeal carcinoma. Oncotarget. 7(18). 26765–26779. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026